Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Amalia Cuesta"'
Autor:
Iñigo Romon, Juan J. Dominguez-Garcia, Jose L. Arroyo, Borja Suberviola, Itxasne Cabezón, Beatriz Abascal, Cristina Baldeón, Amalia Cuesta, Raquel Portilla, Elena Casuso, Enrique Ocio, Montserrat Briz
Publikováno v:
BMC Geriatrics, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Older patients, frequently with multiple comorbidities, have a high mortality from COVID-19 infection. Convalescent plasma (CP) is a therapeutic option for these patients. Our objective is to retrospectively evaluate the efficacy
Externí odkaz:
https://doaj.org/article/45dd2fffa72247b4b6d9d67fed524361
Autor:
Ana Muntañola, Guillermo Villacampa, José Ángel Hernández-Rivas, Rosalía Alonso, Fátima Mirás, Santiago Osorio, Mónica Baile, Patricia Baltasar, Javier López Jiménez, Ines Hernandez-Rodriguez, Susana Valenciano, Ana Alfayate, Eva Gimeno, Abelardo Bárez, Ana C. Oliveira, Rosalía Riaza, Pilar Romero, Julio Delgado, Lucrecia Yáñez, Amaya Zabalza, Ana Torres, Mª Isabel Gómez-Roncero, Marta Crespo, Raúl Córdoba, Juan José Mateos-Mazón, Sonia Pérez, Rafael Andreu, Jorge Labrador, Mª Elena Ruiz, César Andrés Velasquez, Mª José Terol, Raquel Santiago, Mª Jesús Vidal, Fiz Campoy García, Lucía Villalón, Begoña S. Muiña, Joan Alfons Soler, Cristina Seri, Mª José Sánchez, Amalia Cuesta, Rafael Ramos, Adrián Sánchez-Montalvá, Isabel Ruiz-Camps, Marcos González, Pau Abrisqueta, Francesc Bosch, of the GELLC (Grupo Español de Leucemia Linfática Crónica)
Publikováno v:
Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-4 (2020)
Externí odkaz:
https://doaj.org/article/3cb4c5fec4404b34821a7fef7650fb2d
Autor:
Iranzu Ezcurra, Ángela Puente, Antonio Cuadrado, Ibai Tamayo, Paula Iruzubieta, María Teresa Arias-Loste, Francisco José González, Raúl Pellón, Sara Sánchez, Juan Crespo del Pozo, Mercedes Acebo, Marcos López-Hoyos, Rocío Pérez, Amalia Cuesta, Ángela Antón, Víctor Echavarría, Emilio Fábrega, Javier Crespo, Jose Ignacio Fortea
Background and aims: preliminary evidence suggest that inherited hypercoagulable disorders can lead to an increased risk of significant liver fibrosis. We aimed to investigate the prevalence of significant fibrosis in patients with inherited thrombop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ec880cf126b567ab5f49392a81484f3
https://doi.org/10.21203/rs.3.rs-2768032/v1
https://doi.org/10.21203/rs.3.rs-2768032/v1
Autor:
Lindsey E Roeker, Lydia Scarfo, Thomas Chatzikonstantinou, Pau Abrisqueta, Toby A. Eyre, Raul Cordoba, Ana Muntañola Prat, Guillermo Villacampa, Lori A. Leslie, Michael Koropsak, Giulia Quaresmini, John N. Allan, Richard R. Furman, Erica B Bhavsar, John M. Pagel, Jose Angel Hernandez-Rivas, Krish Patel, Marina Motta, Neil Bailey, Fatima Miras, Nicole Lamanna, Rosalia Alonso, Santiago Osorio-Prendes, Candida Vitale, Manali Kamdar, Patricia Baltasar, Anders Österborg, Lotta Hanson, Mónica Baile, Ines Rodríguez-Hernández, Susana Valenciano, Viola Maria Popov, Abelardo Barez Garcia, Ana Alfayate, Ana C Oliveira, Barbara Eichhorst, Francesca M. Quaglia, Gianluigi Reda, Javier Lopez Jimenez, Marzia Varettoni, Monia Marchetti, Pilar Romero, Rosalía Riaza Grau, Talha Munir, Amaya Zabalza, Ann Janssens, Carsten U Niemann, Guilherme Fleury Perini, Julio Delgado, Lucrecia Yanez San Segundo, Ma Isabel Gómez Roncero, Matthew Wilson, Piers Patten, Roberto Marasca, Sunil Iyengar, Amanda Seddon, Ana Torres, Angela Ferrari, Carolina Cuéllar-García, Daniel Wojenski, Dima El-Sharkawi, Gilad Itchaki, Helen Parry, Juan José Mateos-Mazón, Nicolas Martinez-Calle, Shuo Ma, Daniel Naya, Ellen Van Der Spek, Erlene K. Seymour, Eva Gimeno Vázquez, Gian Matteo Rigolin, Francesca Romana Mauro, Harriet S Walter, Jorge Labrador, Lorenzo De Paoli, Luca Laurenti, Elena Ruiz, Mark-David Levin, Martin Šimkovič, Martin Špaček, Rafa Andreu, Renata Walewska, Sonia Perez-Gonzalez, Suchitra Sundaram, Adrian Wiestner, Amalia Cuesta, Angus Broom, Arnon P. Kater, Begoña Muiña, César A Velasquez, Chaitra S. Ujjani, Cristina Seri, Darko Antic, Dominique Bron, Elisabeth Vandenberghe, Elise A. Chong, Enrico Lista, Fiz Campoy García, Giovanni Del Poeta, Inhye Ahn, Jeffrey J. Pu, Jennifer R Brown, Juan Alfonso Soler Campos, Lara Malerba, Livio Trentin, Lorella Orsucci, Lucia Farina, Lucia Villalon, Maria Jesus Vidal, Maria Jose Sanchez, Maria Jose Terol, Maria Rosaria De Paolis, Massimo Gentile, Matthew S. Davids, Mazyar Shadman, Mohamed A Yassin, Myriam Foglietta, Ozren Jaksic, Paolo Sportoletti, Paul M. Barr, Rafael Ramos, Raquel Santiago, Rosa Ruchlemer, Sabina Kersting, Scott F. Huntington, Tobias Herold, Yair Herishanu, Meghan C. Thompson, Sonia Lebowitz, Christine Ryan, Ryan W. Jacobs, Craig A. Portell, Krista Isaac, Alessandro Rambaldi, Chadi Nabhan, Danielle M. Brander, Emili Montserrat, Giuseppe Rossi, Jose A. Garcia-Marco, Marta Coscia, Nikita Malakhov, Noemi Fernandez-Escalada, Sigrid Strand Skånland, Callie C. Coombs, Paola Ghione, Stephen J. Schuster, Robin Foà, Antonio Cuneo, Francesc Bosch, Kostas Stamatopoulos, Paolo Ghia, Anthony R. Mato, Meera Patel
Publikováno v:
Blood
Introduction: Patients (pts) with CLL may be at particular risk of severe COVID-19 given advanced age and immune dysregulation. Two large series with limited follow-up have reported outcomes for pts with CLL and COVID-19 (Scarfò, et al. Leukemia 202
Autor:
Itxasne Cabezón, Elena Casuso, Cristina Baldeón, Raquel Portilla, Amalia Cuesta, José Luis Arroyo, Juan J Dominguez-Garcia, Iñigo Romon, Montserrat Briz, Beatriz Abascal, Enrique M. Ocio, Borja Suberviola
Publikováno v:
BMC Geriatr . 2021 Oct 18;21(1):566
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
BMC Geriatrics
BMC Geriatrics, Vol 21, Iss 1, Pp 1-7 (2021)
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
BMC Geriatrics
BMC Geriatrics, Vol 21, Iss 1, Pp 1-7 (2021)
Background Older patients, frequently with multiple comorbidities, have a high mortality from COVID-19 infection. Convalescent plasma (CP) is a therapeutic option for these patients. Our objective is to retrospectively evaluate the efficacy and adver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeb65069c6447bdb65b0b1a958cafd49
http://hdl.handle.net/10902/23828
http://hdl.handle.net/10902/23828
Autor:
Iranzu Ezcurra, Jose Ignacio Fortea, Angela Puente, Antonio Cuadrado, Ines Garciá, Francisco Jose Gonzalez, Raul Pellon, Sara Sanchez, Juan Crespo, Mercedes Acebo, Marcos López-Hoyos, Mariá del Roció Pérez Montes, Amalia Cuesta, Emilio Fabrega, Javier Crespo
Publikováno v:
Journal of Hepatology. 73:S515-S516
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Amalia Cuesta, Carmen Montes-Gaisan, German Perez, Arancha Bermúdez, Eulogio Conde, Carlos Richard
Publikováno v:
Blood. 124:5890-5890
Background: Post-remission treatment for AML is very aggressive and many times a SCT is needed. Comparisons between Allo-SCT and Auto-SCT ve always shown more Transplant Related Mortality (TRM) but less Cumulative Incidence of Relapse (CIR) in the fi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eulogio Conde, Carlos Richard, Arturo Iriondo, Amalia Cuesta, German Perez, Carmen Montes-Gaisan, Andrés Insunza, Arancha Bermúdez, Guillermo Martin, Susana Herraez
Publikováno v:
Blood. 118:3099-3099
Abstract 3099 Background: Despite the fact that allogeneic SCT currently offers patients with high risk AML the best chance of cure, we've aimed to investigate the outcome of AML patients who have undergone ASCT in our center, considered as one of sp